Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
1) Phase Ib: To estimate the MTD or RP2D of INC280 in combination with gefitinib in NSCLC patients who have c-MET gene dysregulation 2) Phase II: To estimate overall clinical activity of INC280 in combination with gefitinib in NSCLC patients with c-MET gene dysregulation
Critère d'inclusion
- non-small cell lung cancer